{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T17:17:41Z","timestamp":1770743861482,"version":"3.49.0"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2023,5,24]],"date-time":"2023-05-24T00:00:00Z","timestamp":1684886400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,5,24]],"date-time":"2023-05-24T00:00:00Z","timestamp":1684886400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2023,9]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>The ACOSOG-Z0011- and the AMAROS-trial obviated the need for axillary surgery in most sentinel node-positive (SLN+) breast cancer patients undergoing breast-conserving surgery (BCS). Data for patients who undergo mastectomy is scarce. The purpose of this study was to investigate patterns of axillary treatment in SLN+ patients treated by mastectomy in the years after the publication of landmark studies regarding axillary treatment in SLN+ breast cancer patients undergoing BCS.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>This was a population-based study in cT1-3N0M0 breast cancer patients treated by mastectomy and staged as SLN+ between 2009 and 2018. The performance of an axillary lymph node dissection (ALND) and\/or administration of postmastectomy radiotherapy (PMRT) were primary outcomes and were studied over time.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>The study included 10,633 patients. The frequency of ALND performance decreased from 78% in 2009 to 10% in 2018, whereas PMRT increased from 4 to 49% (<jats:italic>P<\/jats:italic> &lt; 0.001). In \u2265N1a patients, ALND performance decreased from 93 to 20%, whereas PMRT increased to 70% (<jats:italic>P<\/jats:italic> &lt; 0.001). In N1mi and N0itc patients, ALND was abandoned during the study period, whereas PMRT increased to 38% and 13% respectively (<jats:italic>P<\/jats:italic> &lt; 0.001), respectively. Age, tumor subtype, N-stage, and hospital type affected the likelihood that patients underwent ALND.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>In this study in SLN+ breast cancer patients undergoing mastectomy, use of ALND decreased drastically over time. By the end of 2018 most \u2265N1a patients received PMRT as the only adjuvant axillary treatment, whereas the majority of N1mi and N0itc patients received no additional treatment.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1245\/s10434-023-13568-3","type":"journal-article","created":{"date-parts":[[2023,5,24]],"date-time":"2023-05-24T17:01:56Z","timestamp":1684947716000},"page":"5623-5632","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Trends of Axillary Treatment in Sentinel Node-Positive Breast Cancer Patients Undergoing Mastectomy"],"prefix":"10.1245","volume":"30","author":[{"given":"Eline E. F.","family":"Verreck","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julia E. C.","family":"van Steenhoven","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne","family":"Kuijer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marissa C.","family":"van Maaren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Janine M.","family":"Simons","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sabine","family":"Siesling","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thijs","family":"van Dalen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,5,24]]},"reference":[{"issue":"6","key":"13568_CR1","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1001\/jama.2011.90","volume":"305","author":"AE Giuliano","year":"2011","unstructured":"Giuliano AE, Hunt KK, Ballman KV, et al. Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial. JAMA. 2011;305(6):569\u201375.","journal-title":"JAMA"},{"issue":"10","key":"13568_CR2","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1001\/jama.2017.11470","volume":"318","author":"AE Giuliano","year":"2017","unstructured":"Giuliano AE, Ballman KV, McCall L, et al. Effect of axillary dissection vs no axillary dissection on 10-year overall survival among women with invasive breast cancer and sentinel node metastasis: the ACOSOG Z0011 (Alliance) Randomized Clinical Trial. JAMA. 2017;318(10):918\u201326.","journal-title":"JAMA"},{"issue":"4","key":"13568_CR3","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/S1470-2045(13)70035-4","volume":"14","author":"V Galimberti","year":"2013","unstructured":"Galimberti V, Cole BF, Zurrida S, et al. Axillary dissection versus no axillary dissection in patients with sentinel-node micrometastases (IBCSG 23\u201301): a phase 3 randomised con- trolled trial. Lancet Oncol. 2013;14(4):297\u2013305.","journal-title":"Lancet Oncol"},{"issue":"12","key":"13568_CR4","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1016\/S1470-2045(14)70460-7","volume":"15","author":"M Donker","year":"2014","unstructured":"Donker M, van Tienhoven G, Straver ME, et al. Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer (EORTC 10981\u201322023 AMAROS): a randomised, multicentre, open-label, phase 3 non-inferiority trial. Lancet Oncol. 2014;15(12):1303\u201310.","journal-title":"Lancet Oncol"},{"key":"13568_CR5","unstructured":"Nationaal Borstkanker Overleg Nederland (NABON). Richtlijn behandeling van het mammacarcinoom. https:\/\/richtlijnendatabase.nl\/richtlijn\/borstkanker\/algemeen.html. Accessed 10 Apr 2021."},{"key":"13568_CR6","unstructured":"National Comprehensive Cancer Network clinical practice guidelines in oncology. Breast cancer (ver 5.2020). https:\/\/www2.tri-kobe.org\/nccn\/guideline\/breast\/english\/breast.pdf. Accessed 7 Apr 2021."},{"issue":"5","key":"13568_CR7","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1200\/JCO.2016.71.0947","volume":"35","author":"GH Lyman","year":"2017","unstructured":"Lyman GH, Somerfield MR, Bosserman LD, Perkins CL, Weaver DL, Giuliano AE. Sentinel lymph node biopsy for patients with early-stage breast cancer: American society of clinical oncology clinical practice guideline update. J Clin Oncol. 2017;35(5):561\u20134.","journal-title":"J Clin Oncol"},{"issue":"6","key":"13568_CR8","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1097\/SLA.0000000000002440","volume":"268","author":"IGM Poodt","year":"2018","unstructured":"Poodt IGM, Spronk PER, Vugts G, et al. Trends on axillary surgery in nondistant metastatic breast cancer patients treated between 2011 and 2015: a Dutch population-based study in the ACOSOG-Z0011 and AMAROS Era. Ann Surg. 2018;268(6):1084\u201390.","journal-title":"Ann Surg"},{"issue":"6","key":"13568_CR9","doi-asserted-by":"publisher","first-page":"712e9","DOI":"10.3109\/0284186X.2015.1136751","volume":"55","author":"A Gondos","year":"2016","unstructured":"Gondos A, Jansen L, Heil J, et al. Time trends in axilla management among early breast cancer patients: persisting major variation in clinical practice across European centers. Acta Oncol. 2016;55(6):712e9.","journal-title":"Acta Oncol"},{"issue":"17","key":"13568_CR10","doi-asserted-by":"publisher","first-page":"3579","DOI":"10.1016\/j.ejca.2013.07.017","volume":"49","author":"ARM Wilson","year":"2013","unstructured":"Wilson ARM, Marotti L, Bianchi S, et al. The requirements of a specialist Breast Centre. Eur J Cancer. 2013;49(17):3579\u201387.","journal-title":"Eur J Cancer"},{"issue":"2","key":"13568_CR11","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1097\/SLA.0000000000002095","volume":"267","author":"RA Greenup","year":"2018","unstructured":"Greenup RA, Obeng-Gyasi S, Thomas S, et al. The effect of hospital volume on breast cancer mortality. Ann Surg. 2018;267(2):375\u201381.","journal-title":"Ann Surg"},{"key":"13568_CR12","first-page":"JCO2201565","volume":"2022","author":"SA Bartels","year":"2022","unstructured":"Bartels SA, Donker M, Poncet C, et al. Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer: 10-year result of the randomized controlled EORTC 10981\u201322023 AMAROS trial. J Clin Oncol. 2022;2022:JCO2201565.","journal-title":"J Clin Oncol"},{"issue":"2","key":"13568_CR13","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1007\/s10549-019-05243-7","volume":"176","author":"A Weiss","year":"2019","unstructured":"Weiss A, Lin H, Babiera GV, et al. Evolution in practice patterns of axillary management following mastectomy in patients with 1\u20132 positive sentinel nodes. Breast Cancer Res Treat. 2019;176(2):435\u201344.","journal-title":"Breast Cancer Res Treat"},{"issue":"8","key":"13568_CR14","doi-asserted-by":"publisher","first-page":"2435","DOI":"10.1245\/s10434-019-07388-7","volume":"26","author":"A Hennigs","year":"2019","unstructured":"Hennigs A, Riedel F, Fei\u00dft M, et al. Evolution of the use of completion axillary limph node dissection in patients with T1\/2N0M0 breast cancer and tumour-involved sentinel lymph nodes undergoing mastectomy: a cohort study. Ann Surg Oncol. 2019;26(8):2435\u201343.","journal-title":"Ann Surg Oncol"},{"issue":"8","key":"13568_CR15","doi-asserted-by":"publisher","first-page":"2220","DOI":"10.1245\/s10434-018-6409-6","volume":"25","author":"S Gaines","year":"2018","unstructured":"Gaines S, Suss N, Barrera E, et al. Axillary surgery for early-stage, node-positive mastectomy patients and the use of postmastectomy chest wall radiation therapy. Ann Surg Oncol. 2018;25(8):2220\u20138.","journal-title":"Ann Surg Oncol"},{"key":"13568_CR16","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-021-10726-3","author":"O Kantor","year":"2021","unstructured":"Kantor O, Means J, Grossmith S, et al. Optimizing axillary management in clinical T1\u20132N0 mastectomy patients with positive sentinel lymph nodes. Ann Surg Oncol. 2021. https:\/\/doi.org\/10.1245\/s10434-021-10726-3.","journal-title":"Ann Surg Oncol"},{"key":"13568_CR17","unstructured":"Nationaal Borstkanker Overleg Nederland (NABON). Richtlijn Behandeling van het Mammacarcinoom 2012. https:\/\/www.nabon.nl\/wp-content\/uploads\/2022\/11\/Richtlijn-mammacarcinoom-2012.pdf. Accessed 8 Mar 2023."},{"issue":"9","key":"13568_CR18","first-page":"2612","volume":"25","author":"M Moossdorff","year":"2018","unstructured":"Moossdorff M, Nakhlis F, Hu J, et al. The potential impact of AMAROS on the management of the axilla in patients with clinical T1\u20132N0 breast cancer undergoing primary total mastectomy. Ann Surg. 2018;25(9):2612\u20139.","journal-title":"Ann Surg"},{"issue":"1","key":"13568_CR19","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1245\/s10434-012-2569-y","volume":"20","author":"M Sol\u00e1","year":"2013","unstructured":"Sol\u00e1 M, Alberro JA, Fraile M, et al. Complete axillary lymph node dissection versus clinical follow-up in breast cancer patients with sentinel node micrometastasis: final results from the multicenter clinical trial AATRM 048\/13\/2000. Ann Surg Oncol. 2013;20(1):120\u20137.","journal-title":"Ann Surg Oncol"},{"key":"13568_CR20","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1007\/s10549-019-05520-5","volume":"180","author":"AB Tadros","year":"2020","unstructured":"Tadros AB, Moo TA, Stempel M, Zabor EC, Khan AJ, Morrow M. Axillary management for young women with breast cancer varies between patients electing breast-conservation therapy or mastectomy. Breast Cancer Res Treat. 2020;180:197\u2013205.","journal-title":"Breast Cancer Res Treat"},{"key":"13568_CR21","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.breast.2016.06.016","volume":"30","author":"C Tinterri","year":"2016","unstructured":"Tinterri C, Canavese G, Bruzzi P, Dozin B. SINODAR ONE, an ongoing randomized clinical trial to assess the role of axillary surgery in breast cancer patients with one or two macrometastatic sentinel nodes. Breast. 2016;30:197\u2013200.","journal-title":"Breast"},{"issue":"1","key":"13568_CR22","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1186\/s12885-017-3361-y","volume":"17","author":"J de Boniface","year":"2017","unstructured":"de Boniface J, Frisell J, Andersson Y, et al. Survival and axillary recurrence following sentinel node-positive breast cancer without completion axillary lymph node dissection: the randomized controlled SENOMAC trial. BMC Cancer. 2017;17(1):379.","journal-title":"BMC Cancer"},{"issue":"12","key":"13568_CR23","doi-asserted-by":"publisher","first-page":"e054365","DOI":"10.1136\/bmjopen-2021-054365","volume":"11","author":"A Goyal","year":"2021","unstructured":"Goyal A, Mann GB, Fallowfield L, et al. POSNOC-POsitive Sentinel NOde: adjuvant therapy alone versus adjuvant therapy plus Clearance or axillary radiotherapy: a randomised controlled trial of axillary treatment in women with early-stage breast cancer who have metastases in one or two sentinel nodes. BMJ Open. 2021;11(12):e054365.","journal-title":"BMJ Open"},{"key":"13568_CR24","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1186\/s12885-015-1613-2","volume":"15","author":"LM Van Roozendaal","year":"2015","unstructured":"Van Roozendaal LM, de Wilt JHW, van Dalen T, et al. The value of completion axillary treatment in sentinel node positive breast cancer patients undergoing a mastectomy: a Dutch randomized controlled multicentre trial (BOOG 2013\u201307). BMC Cancer. 2015;15:610.","journal-title":"BMC Cancer"},{"key":"13568_CR25","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.radonc.2018.07.006","volume":"131","author":"ML Gregorowitsch","year":"2019","unstructured":"Gregorowitsch ML, Verkooijen HM, Houweling A, et al. Impact of modern-day axillary treatment on patients reported arm morbidity and physical functioning in breast cancer patients. Radiother Oncol. 2019;131:221\u20138.","journal-title":"Radiother Oncol"}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-023-13568-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1245\/s10434-023-13568-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-023-13568-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,8]],"date-time":"2023-08-08T13:06:59Z","timestamp":1691500019000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1245\/s10434-023-13568-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,24]]},"references-count":25,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["13568"],"URL":"https:\/\/doi.org\/10.1245\/s10434-023-13568-3","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,24]]},"assertion":[{"value":"7 February 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 April 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 May 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors report no conflicts of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"DISCLOSURES"}},{"value":"This article does not contain any studies involving animals performed by any of the authors. All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}}]}}